Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 894 of 1,261
  1. US 8334282

    Cannabinoid receptor antagonists/inverse agonists useful for treating metabolic disorders, including obesity and diabetes

    Jenrin Discovery, LLC · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted
  2. US 8334239

    High affinity VEGF-receptor antagonists

    The Board of Regents of the University of Texas System · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted
  3. US 8334373

    Nuclease resistant double-stranded ribonucleic acid

    Alnylam Pharmaceuticals, Inc. · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted
  4. US 8333959

    Ex-vivo application of solid microparticulate therapeutic agents

    Board of Regents of the University of Nebraska by and behalf of the University of Nebraska Medical Center · Granted Dec 18, 2012 · Expires Dec 13, 2032

    granted
  5. CA 2838876

    COMPOSITIONS ET PROCEDES DE TRAITEMENT, DE SUPPRESSION, DE REDUCTION OU D'AMELIORATION D'UNE DOULEUR INFLAMMATOIRE

    BAUSCH & LOMB [US] · Granted Dec 13, 2012 · Expires Dec 8, 2032

    granted
  6. US 8329182

    Immunoglobulin chimeric monomer-dimer hybrids

    Syntonix Pharmaceuticals, Inc. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  7. US 8329179

    Death domain containing receptor 4 antibodies and methods

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  8. US 8329141

    Locoregional internal radionuclide ablation of abnormal tissues

    The Board of Regents of the University of Texas System · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  9. US 8329205

    Bioabsorbable composition and coatings of a fatty acid salt, epsilon-caprolactone, a monomer, and homopolymers or copolymers

    Covidien LP · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  10. US 8329924

    Compounds and methods for the treatment or prevention of Flavivirus infections

    Vertex Pharmaceuticals (Canada) Incorporated · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  11. US 8329911

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  12. US 8329900

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  13. US 8329876

    Thioester-terminated water soluble polymers and method of modifying the N-terminus of a polypeptide therewith

    Nektar Therapeutics · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  14. US 8328785

    Use of nanoparticles in the photodynamic treatment of tumors

    The Board of Regents of the University of Texas System · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  15. US 8329703

    Pyrazole compounds

    XTL BIOPHARMACEUTICALS LTD. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  16. US 8329744

    Methods of preventing the serotonin syndrome and compositions for use thereof

    Relmada Therapeutics, Inc. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  17. US 8329181

    Methods for treating B-cell lymphoma by administering an anti-CD20 antibody

    REGENERON PHARMACEUTICALS, INC. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  18. US 8329745

    Small molecule inhibitors of ghrelin O-acyltransferase

    The Board of Regents of the University of Texas System · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  19. US 8329753

    Combination of compounds, or a bifunctional compound, that provides fatty acid metabolism and glycolysis inhibition

    The Regents of the University of Colorado · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  20. US 8329845

    Divided redox-curing type composition

    KURARAY NORITAKE DENTAL INC. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  21. US 8329702

    Heterocycles useful as modulators of ion channels

    Vertex Pharmaceuticals Incorporated · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  22. US 8329687

    Pyridooxazepine derivative and use thereof

    Takeda Pharmaceutical Company Limited · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  23. US 8329664

    Anti-viral pyrimidine nucleoside derivatives

    University College Cardiff Consultants Limited · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted
  24. US 8329696

    Solid state forms of sitagliptin salts

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 11, 2012 · Expires Dec 6, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.